Resolution Announces Fibrosis Presentation at Keystone Symposia
10 Dec 2024 //
PR NEWSWIRE
Resolution Expands RTX001 Phase 1/2 EMERALD Study into Spain
19 Nov 2024 //
PR NEWSWIRE
Resolution Therapeutics Presents Data for RTX001 in Liver Disease
11 Nov 2024 //
PR NEWSWIRE
Resolution Therapeutics Raises £63.5M In Series B, Appoints Chair
03 Oct 2024 //
PR NEWSWIRE